1·Objective: To study a new method in the treatment of late liver carcinoma.
目的：研究一种治疗晚期肝癌的新方法。
2·Primary liver carcinoma is one of the malignant tumors seriously threatening the health of mankind.
原发性肝癌是严重威胁人类健康的最常见的恶性肿瘤之一。
3·Objective To summarize the diagnosis and treatment of spontaneous rupture of primary liver carcinoma.
目的探讨原发性肝癌破裂出血的诊断和治疗。
4·Objective TO compare the therapeutic efficacy of TOCE and s TOCE in treatment of small liver carcinoma.
目的探讨常规栓塞化疗(TOCE)与节段性栓塞化疗(S TOCE)在小肝癌治疗中的疗效比较。
5·The results showed that to small peripheral liver carcinoma, regional blood blockage must be the choice;
研究结果表明：周边型的较小肝癌应选择局部血流控制法；
6·To establish hepatocellular carcinoma (HCC) cell lines and provide more pure liver carcinoma cells for HCC studies.
建立新的肝细胞癌细胞系，为肝癌实验研究提供更多纯化癌细胞。
7·Objective: To observe the pathological and molecular changes of the primary liver carcinoma after chemoembolization.
探讨肝癌肝动脉栓塞化疗后肿瘤的病理及某些分子生物学的变化。
8·Conclusions PEI for liver carcinoma has the advantage of mini-wound, extensive application scope and reliable effects.
结论PEI治疗肝肿瘤，具有创伤小、适用范围广、疗效确切等优点。
9·Aim: To investigate the state of systemic and splenic cellular immunity in patients with primary liver carcinoma (PLC).
目的：探讨原发性肝癌(PLC)患者全身及脾脏的细胞免疫状态。
10·Objective To investigate the proper selection of methods of hepatic vascular control during (resection) of liver carcinoma.
目的探讨肝癌切除术中不同肝血流控制方法的合理选择。